Alpha 2.0
Login Register
» Articles » PMID: 28017819

Action of Tocilizumab on Energy Expenditure in Rheumatoid Arthritis: A Prospective Study Using Calorimetry and Actimetry

Overview
Journal Joint Bone Spine
Specialty Rheumatology
Date 2016 Dec 27
PMID 28017819
Citations 3
Authors
Marie Hugo
Audrey Pierreisnard
Nadia Mehsen-Cetre
Henri Gin
Thierry Schaeverbeke
Vincent Rigalleau
Affiliations
Soon will be listed here.
Citing Articles

Interaction effect of systemic inflammation and modifiable rheumatoid cachexia risk factors on resting energy expenditure in patients with rheumatoid arthritis.

Hanaoka B, Zhao J, Heitman K, Khan F, Jarjour W, Volek J JCSM Clin Rep. 2024; 7(1):12-23.

PMID: 38288252 PMC: 10824535. DOI: 10.1002/crt2.45.

Effects of biologic and target synthetic disease-modifying anti-rheumatic drugs on sarcopenia in spondyloarthritis and rheumatoid arthritis: a systematic review and meta-analysis.

Ben Tekaya A, Mehmli T, Ben Sassi M, Teyeb Z, Bouden S, Rouached L Clin Rheumatol. 2022; 42(4):979-997.

PMID: 36462127 DOI: 10.1007/s10067-022-06454-y.

The Interrelations between Biological and Targeted Synthetic Agents Used in Inflammatory Joint Diseases, and Obesity or Body Composition.

Toussirot E Metabolites. 2020; 10(3).

PMID: 32183053 PMC: 7175105. DOI: 10.3390/metabo10030107.